Found 102 matching trials
Prediction of Response to 2nd-line Hormone Therapy by FES CT/PET in Patients With Metastatic Breast Cancer NA Clinicians are currently proposing second-line hormonal treatment to a meta...
Show More Location
Institut de Cancerologie de l'Ouest
Learn More & Join Trial
Evaluation of an Intervention to Reduce the Time to Treatment for TAVI Patients NA Aortic stenosis (AS) is the most frequent valvulopathy in Western countries...
Show More Location
Brest University Hospital
Learn More & Join Trial
MesomiR 1: A Phase I Study of TargomiRs as 2nd or 3rd Line Treatment for Patients With Recurrent MPM and NSCLC PHASE1 The first testing of TargomiRs in the human setting: dose-finding studies i...
Show More Location
Concord Repatriation General Hospital
Learn More & Join Trial
Management of Chronic Pain and PTSD in Gulf War Veterans With tDCS+Prolonged Exposure NA Gulf War Veterans (a DoD/VA defined service era corresponding to the first ...
Show More Location
The University of Texas Health Science Center at Houston
Learn More & Join Trial
Autologous CD8+ and CD4+ Transgenic T Cells Expressing High Affinity KRASG12V Mutation-Specific T Cell Receptors (FH-A11KRASG12V-TCR) in Treating Patients With Metastatic Solid Tumor Cancers With KRAS G12V Mutations PHASE1 This phase I trial studies the side effects and best dose of autologous CD8...
Show More Location
Fred Hutch/University of Washington Cancer Consortium
Learn More & Join Trial
Genetically Engineered PBMC and PBSC Expressing NY-ESO-1 TCR After a Myeloablative Conditioning Regimen to Treat Patients With Advanced Cancer PHASE1 This phase I clinical trial evaluates the safety and feasibility of adminis...
Show More Location
UCLA / Jonsson Comprehensive Cancer Center
Learn More & Join Trial
WARRIOR Ancillary Study for CCTA Analysis N/A In this study, quantitative characterization of plaque using coronary compu...
Show More Location
Cedars-Sinai Medical Center
Learn More & Join Trial
BIOMARKER and IMAGING CHARACTERISATION of INFLAMMATORY ATHEROMA in PATIENTS RECEIVING IMMUNOTHERAPY and ANGIOGENESIS INHIBITORS N/A The advent of immunotherapy (immune checkpoint inhibitors \[ICI\]) has been...
Show More Status
Active Not Recruiting
Location
Beatson West of Scotland Cancer Centre
Learn More & Join Trial
Safety Study of Adjuvant Vaccine to Treat Melanoma Patients PHASE1 The incidence of melanoma is increasing with an estimated incidence of 59,9...
Show More Location
New York University Langone Medical Center
Learn More & Join Trial
177^Lu-PSMA-617 in Combination With Sipuleucel-T for the Treatment of Metastatic Castration-Resistant Prostate Cancer PHASE1 This phase I trial compares the effect of lutetium Lu 177 (177\^Lu)-prostat...
Show More Location
City of Hope Medical Center
Learn More & Join Trial